Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
August 11 2022 - 6:21AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 or 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2022
Commission File Number: 001-40207
Waldencast plc
(Translation of
Registrant’s name into English)
10 Bank Street, Suite 560
White Plains, New York, 10606
(Address of
principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
On August 11, 2022, Waldencast plc (the “Company”)
will host a conference call and simultaneous webcast to discuss the Company’s financial results for the three and six months ended
June 30, 2022. An archived replay of the webcast and the investor presentation used during the webcast will be available shortly after
the live event has concluded in the Investors section of the Company’s website, https://ir.waldencast.com. A copy of the Company’s
press release and earnings release supplement for the three and six months ended June 30, 2022 is attached as Exhibit 99.1 and Exhibit
99.2, respectively, to this Quarterly Report on Form 6-K and is incorporated by reference herein.
In addition, the Company’s Quarterly Report
for the three and six months ended June 30, 2022 is attached as Exhibit 99.3 to this Quarterly Report on Form 6-K and is incorporated
by reference herein. The Company is also providing supplemental information for the financial results for the six months ended June 30,
2022 for each of Obagi Global Holdings Limited, a Cayman Islands exempted company limited by shares, and Milk Makeup LLC, a Delaware limited
liability company, which is attached as Exhibit 99.4 and 99.5, respectively, to this Quarterly Report on Form 6-K and is incorporated
by reference herein.
EXHIBIT INDEX
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, Waldencast plc has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
Waldencast plc |
|
|
(Registrant) |
|
|
|
|
Date: August 11, 2022 |
By: |
/s/ Michel Brousset |
|
|
Name: |
Michel Brousset |
|
|
Title: |
Chief Executive Officer and Principal Financial Officer |
3
Waldencast Acquisition (NASDAQ:WALDU)
Historical Stock Chart
From May 2024 to Jun 2024
Waldencast Acquisition (NASDAQ:WALDU)
Historical Stock Chart
From Jun 2023 to Jun 2024